COVID-19 Vaccination Hesitancy: The Science, Theory, and Messaging   [open pdf - 0B]

From the Document: "Few evidence-based treatments for COVID-19 [coronavirus disease 2019] have been tested as efficacious or made available to the public. Yet, three vaccines have been authorized for emergency use by the FDA (Johnson & Johnson, Moderna, Pfizer). As such, strict public health measures including isolation, social distancing, quarantine of those infected or exposed, community containment, limiting social gatherings, frequent handwashing, and face mask utilization have been mandated. [...] In early March 2021, Texas will lift many of the government restrictions. To reduce the spread of COVID-19, the continuation of these measures, coupled with rapid and widespread vaccination of the population, is strongly recommended. While in these initial phases of vaccine distribution, demand for the vaccine is outpacing supply. It is clear from previous pandemics, other vaccine uptake, and studies of COVID-19 vaccines, that a non-trivial portion of U.S. residents -- and those residing on the border of the U.S. and Mexico -- will either be hesitant to become vaccinated or refuse to do so. To reduce viral spread, hospitalizations, and deaths, strong messaging and outreach efforts to promote vaccination by large numbers of residents in the region are vital. As no best practices for doing so exist, assessing the state of the science, using strong theoretical underpinnings and formative processes, such as community-based focus groups and collaboration from multiple stakeholders, is optimal to develop messaging and outreach strategies."

University of Texas at El Paso
Retrieved From:
Reduce the Risk: https://www.reducetherisk915.org/
Media Type:
Help with citations